EDIT logo

Editas Medicine (EDIT) Company Overview

Profile

Full Name:

Editas Medicine, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

February 3, 2016

Indexes:

Not included

Description:

Editas Medicine, Inc. is a pharmaceutical company based in Cambridge, Massachusetts, developing treatment methods based on CRISPR-Cas9 gene editing technology. Editas Medicine, Inc. was founded in 2013. Editas Medicine is a leading genome editing company at the clinical stage, working on the development of potentially transformative genomic medicines for a wide range of serious diseases. The company has developed its own genome editing platform based on CRISPR technology. Editas Medicine's main developments are in the field of eye diseases and engineered cell therapies for the treatment of hemoglobinopathies and cancer.

Key Details

Price

$1.96

Annual Revenue

$78.12 M(+296.32% YoY)

Annual EPS

-$2.02(+37.07% YoY)

Annual ROE

-43.17%

Beta

2.16

Events Calendar

Earnings

Next earnings date:

Mar 5, 2025

Recent quarterly earnings:

Nov 4, 2024

Recent annual earnings:

Feb 28, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Dec 16, 24 JP Morgan
Underweight
Dec 16, 24 Evercore ISI Group
Outperform
Dec 13, 24 Stifel
Hold
Dec 13, 24 RBC Capital
Sector Perform
Dec 13, 24 Chardan Capital
Neutral
Dec 13, 24 Barclays
Equal-Weight
Dec 13, 24 Baird
Outperform
Dec 11, 24 Wells Fargo
Equal-Weight
Nov 5, 24 Wells Fargo
Overweight
Nov 5, 24 Truist Securities
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Editas Medicine?
  • Does Editas Medicine pay dividends?
  • What sector is Editas Medicine in?
  • What industry is Editas Medicine in?
  • What country is Editas Medicine based in?
  • When did Editas Medicine go public?
  • Is Editas Medicine in the S&P 500?
  • Is Editas Medicine in the NASDAQ 100?
  • Is Editas Medicine in the Dow Jones?
  • When was Editas Medicine's last earnings report?
  • When does Editas Medicine report earnings?
  • Should I buy Editas Medicine stock now?

What is the ticker symbol for Editas Medicine?

The ticker symbol for Editas Medicine is NASDAQ:EDIT

Does Editas Medicine pay dividends?

No, Editas Medicine does not pay dividends

What sector is Editas Medicine in?

Editas Medicine is in the Healthcare sector

What industry is Editas Medicine in?

Editas Medicine is in the Biotechnology industry

What country is Editas Medicine based in?

Editas Medicine is headquartered in United States

When did Editas Medicine go public?

Editas Medicine's initial public offering (IPO) was on February 3, 2016

Is Editas Medicine in the S&P 500?

No, Editas Medicine is not included in the S&P 500 index

Is Editas Medicine in the NASDAQ 100?

No, Editas Medicine is not included in the NASDAQ 100 index

Is Editas Medicine in the Dow Jones?

No, Editas Medicine is not included in the Dow Jones index

When was Editas Medicine's last earnings report?

Editas Medicine's most recent earnings report was on Nov 4, 2024

When does Editas Medicine report earnings?

The next expected earnings date for Editas Medicine is Mar 5, 2025

Should I buy Editas Medicine stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions